All News #Library
Biotech
Replay, MDA IND Cleared for PRAME TCR-NK Cell Therapy
30 Apr 2024 //
GLOBENEWSWIRE
Syena announces first patient dosed in Phase 1/2 study of TCR-NK cell therapy
11 Mar 2024 //
GLOBENEWSWIRE
Syena and Miltenyi enter into GMP agreement for PRAME TCR-NK cell therapy
18 Dec 2023 //
GLOBENEWSWIRE
Replay, MD Anderson form near-clinical TCR-NK cell therapy firm
14 Feb 2023 //
FIERCE BIOTECH

Market Place
Sourcing Support